91 related articles for article (PubMed ID: 9203632)
1. Correlation between the formation of cleavable complex with topoisomerase I and growth-inhibitory activity for saintopin-type antibiotics.
Fujii N; Yamashita Y; Mizukami T; Nakano H
Mol Pharmacol; 1997 Feb; 51(2):269-76. PubMed ID: 9203632
[TBL] [Abstract][Full Text] [Related]
2. Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus.
Yamashita Y; Kawada S; Fujii N; Nakano H
Biochemistry; 1991 Jun; 30(24):5838-45. PubMed ID: 1646001
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins.
Taniguchi K; Kohno K; Kawanami K; Wada M; Kanematsu T; Kuwano M
Cancer Res; 1996 May; 56(10):2348-54. PubMed ID: 8625310
[TBL] [Abstract][Full Text] [Related]
4. Saintopin, a new antitumor antibiotic with topoisomerase II dependent DNA cleavage activity, from Paecilomyces.
Yamashita Y; Saitoh Y; Ando K; Takahashi K; Ohno H; Nakano H
J Antibiot (Tokyo); 1990 Oct; 43(10):1344-6. PubMed ID: 2175304
[No Abstract] [Full Text] [Related]
5. Novel selective inhibitors for human topoisomerase I, BM2419-1 and -2 derived from saintopin.
Ishiyama D; Futamata K; Futamata M; Kasuya O; Kamo S; Yamashita F; Kanazawa S
J Antibiot (Tokyo); 1998 Dec; 51(12):1069-74. PubMed ID: 10048564
[TBL] [Abstract][Full Text] [Related]
6. Saintopin, a dual inhibitor of DNA topoisomerases I and II, as a probe for drug-enzyme interactions.
Leteurtre F; Fujimori A; Tanizawa A; Chhabra A; Mazumder A; Kohlhagen G; Nakano H; Pommier Y
J Biol Chem; 1994 Nov; 269(46):28702-7. PubMed ID: 7961822
[TBL] [Abstract][Full Text] [Related]
7. UCE6, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from actinomycetes.
Fujii N; Yamashita Y; Chiba S; Uosaki Y; Saitoh Y; Tuji Y; Nakano H
J Antibiot (Tokyo); 1993 Jul; 46(7):1173-4. PubMed ID: 8395492
[No Abstract] [Full Text] [Related]
8. UCE6, a new antitumor antibiotic with topoisomerase I-mediated DNA cleavage activity produced by actinomycetes: producing organism, fermentation, isolation and biological activity.
Fujii N; Tanaka F; Yamashita Y; Ashizawa T; Chiba S; Nakano H
J Antibiot (Tokyo); 1997 Jun; 50(6):490-5. PubMed ID: 9268005
[TBL] [Abstract][Full Text] [Related]
9. UCE1022, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from Paecilomyces.
Fujii N; Yamashita Y; Ando K; Agatsuma T; Saitoh Y; Gomi K; Nishiie Y; Nakano H
J Antibiot (Tokyo); 1994 Aug; 47(8):949-51. PubMed ID: 7928685
[No Abstract] [Full Text] [Related]
10. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.
Hsiang YH; Liu LF
Cancer Res; 1988 Apr; 48(7):1722-6. PubMed ID: 2832051
[TBL] [Abstract][Full Text] [Related]
11. Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives.
Yamashita Y; Fujii N; Murakata C; Ashizawa T; Okabe M; Nakano H
Biochemistry; 1992 Dec; 31(48):12069-75. PubMed ID: 1333791
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of cytotoxicity of N-[2-(dimethylamino)ethyl] acridine-4-carboxamide and of its 7-chloro derivative: the roles of topoisomerases I and II.
Bridewell DJ; Finlay GJ; Baguley BC
Cancer Chemother Pharmacol; 1999; 43(4):302-8. PubMed ID: 10071981
[TBL] [Abstract][Full Text] [Related]
13. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.
Wassermann K; Markovits J; Jaxel C; Capranico G; Kohn KW; Pommier Y
Mol Pharmacol; 1990 Jul; 38(1):38-45. PubMed ID: 2164630
[TBL] [Abstract][Full Text] [Related]
14. DNA topoisomerase II as the primary target of anti-tumor anthracyclines.
Zunino F; Capranico G
Anticancer Drug Des; 1990 Nov; 5(4):307-17. PubMed ID: 1963303
[TBL] [Abstract][Full Text] [Related]
15. Effect of topoisomerase poisoning by antitumor drugs VM 26, fostriecin and camptothecin on DNA repair replication by mammalian cell extracts.
Frosina G; Rossi O
Carcinogenesis; 1992 Aug; 13(8):1371-7. PubMed ID: 1323426
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor agents targeting mammalian topoisomerases].
Nakano H
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1550-5. PubMed ID: 1651681
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
Kong XB; Rubin L; Chen LI; Ciszewska G; Watanabe KA; Tong WP; Sirotnak FM; Chou TC
Mol Pharmacol; 1992 Feb; 41(2):237-44. PubMed ID: 1311406
[TBL] [Abstract][Full Text] [Related]
18. Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110.
Yoshinari T; Yamada A; Uemura D; Nomura K; Arakawa H; Kojiri K; Yoshida E; Suda H; Okura A
Cancer Res; 1993 Feb; 53(3):490-4. PubMed ID: 8381047
[TBL] [Abstract][Full Text] [Related]
19. Aclacinomycin A stabilizes topoisomerase I covalent complexes.
Nitiss JL; Pourquier P; Pommier Y
Cancer Res; 1997 Oct; 57(20):4564-9. PubMed ID: 9377570
[TBL] [Abstract][Full Text] [Related]
20. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
